BioNexus Gene Lab Corp. (BGLC)
BGLC Stock Price Chart
Explore BioNexus Gene Lab Corp. interactive price chart. Choose custom timeframes to analyze BGLC price movements and trends.
BGLC Company Profile
Discover essential business fundamentals and corporate details for BioNexus Gene Lab Corp. (BGLC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
8 Jan 2021
Employees
30.00
Website
https://www.bionexusgenelab.comCEO
Su-Leng Tan
Description
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
BGLC Financial Timeline
Browse a chronological timeline of BioNexus Gene Lab Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 18 Aug 2025
EPS came in at -$0.34 , while revenue for the quarter reached $2.26M .
Earnings released on 15 May 2025
EPS came in at -$0.03 , while revenue for the quarter reached $2.14M .
Earnings released on 15 Apr 2025
EPS came in at -$0.19 , while revenue for the quarter reached $2.52M .
Stock split effective on 7 Apr 2025
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 Nov 2024
EPS came in at -$0.20 , while revenue for the quarter reached $2.63M .
Earnings released on 14 Aug 2024
EPS came in at $0.10 , while revenue for the quarter reached $1.97M .
Earnings released on 31 May 2024
EPS came in at -$0.18 , while revenue for the quarter reached $2.57M .
Earnings released on 31 May 2024
EPS came in at -$0.11 , while revenue for the quarter reached $2.84M .
Earnings released on 31 May 2024
EPS came in at -$0.05 , while revenue for the quarter reached $2.38M .
Earnings released on 15 May 2024
EPS came in at -$0.18 , while revenue for the quarter reached $2.38M .
Earnings released on 29 Mar 2024
EPS came in at $0.17 , while revenue for the quarter reached $2.27M .
Earnings released on 20 Nov 2023
EPS came in at -$0.20 , while revenue for the quarter reached $2.55M .
Stock split effective on 20 Jul 2023
Shares were split 1 : 12 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2022
EPS came in at -$0.05 , while revenue for the quarter reached $2.58M .
Earnings released on 15 Aug 2022
EPS came in at -$0.10 , while revenue for the quarter reached $2.49M .
Earnings released on 16 May 2022
EPS came in at $0.01 , while revenue for the quarter reached $3.03M .
Earnings released on 6 Apr 2022
EPS came in at $0.06 , while revenue for the quarter reached $3.25M .
Earnings released on 15 Nov 2021
EPS came in at $0.21 , while revenue for the quarter reached $3.58M .
Earnings released on 12 Aug 2021
EPS came in at $0.02 , while revenue for the quarter reached $3.09M .
Earnings released on 18 May 2021
EPS came in at $0.24 , while revenue for the quarter reached $3.45M .
Earnings released on 30 Mar 2021
EPS came in at $1.47 , while revenue for the quarter reached $11.36M .
Earnings released on 3 Nov 2020
EPS came in at $0.27 , while revenue for the quarter reached $23.47K .
BGLC Stock Performance
Access detailed BGLC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.